Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US81663L2007
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00XDHY5P9
WGS
GeneDx Holdings Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $GRLZ
NAME
GeneDx Holdings Corp
ISIN
US81663L2007
TICKER
WGS
MIC
XNAS
REUTERS
WGS.OQ
BLOOMBERG
WGS US
Mo., 24.08.2026       GeneDx
US81663L2007

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new data published in Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), in collaboration with the clinical genetics team at Seattle Children’s. The study demonst...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 11.08.2026       GeneDx
US81663L2007

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced the launch of a new online offering designed to expand accessibility of exome testing across the U.S. at scale for pediatric patients with global developmental delay (GDD), intellectual disability (ID) or epilepsy. F...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 06.08.2026       GeneDx
US81663L2007

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences: Canaccord Genuity 46th Annual Growth Conference Boston, MA Fireside Chat: Tuesday, August 11 at 11:00 a.m. ET Wells Fargo 21st Annua...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 03.08.2026       GeneDx
US81663L2007

GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the second quarter of 2026. “Our team’s unwavering focus and agility drove a strong second quarter. By delivering healthy revenue, volume, and gross margin growth, we successfu...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 03.08.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - August 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 03.08.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.This press re...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 03.08.2026       GeneDx
US81663L2007

LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 03.08.2026       GeneDx
US81663L2007

LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunde...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
So., 02.08.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
So., 02.08.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - August 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx com...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Sa., 01.08.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Sa., 01.08.2026       GeneDx
US81663L2007

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise a...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 31, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 31, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholder...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 31, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereund...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 31.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 30.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 30, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 30.07.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - July 30, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx cla...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 30.07.2026       GeneDx
US81663L2007

Key Dates and Disclosure Events GeneDx Shareholders Need to Know: From $51 Million Acquisition Promise to $31.2 Million Write-Off in Just 12 MonthsNEW YORK, July 30, 2026 /PRNewswire/ -- SueWallSt alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) of a pending securities class action. April 16, 2025. May 5, 2025. July 29, 2025. October 28, 20...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 30.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mi., 29.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 29, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mi., 29.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 29, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mi., 29.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 29, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mi., 29.07.2026       GeneDx
US81663L2007

Time-Sensitive: Allegations Focus on Deteriorating Reimbursement Rates and Margin Compression Concealed From GeneDx InvestorsNEW YORK, July 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) of a pending securities class action. Class Period: April 16, 2025 through May 4, 2026. Check if you c...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 28, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

NEW YORK, July 28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GeneDx Holdings Corp. (NASDAQ: WGS). Shareholders who purchased shares of WGS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - July 28, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 28, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereund...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       GeneDx
US81663L2007

NEW YORK, July 28, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       GeneDx
US81663L2007

Lead Plaintiff Deadline: August 3, 2026SAN DIEGO, July 27, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the "Class Period")...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 27, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 27, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Mo., 27.07.2026       GeneDx
US81663L2007

LOS ANGELES, July 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholder...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Sa., 25.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Sa., 25.07.2026       GeneDx
US81663L2007

NEW ORLEANS, July 24, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS), if they purchased or otherwise acquired the Company's shares between April 16,...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - July 24, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 24, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed, and the firm is actively urging investors with substantial losses contact the firm now. The upcoming lead plaintiff deadline is August 3, 2026....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Fr., 24.07.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       GeneDx
US81663L2007

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026. GeneDx describes itself as an “American biotechnology company specializing in genomic diagnostics, with a focus on whole genome seque...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       GeneDx
US81663L2007

GeneDx Stock Plunged 49% After May 2026 Disclosure Revealed $31.2 Million Fabric Genomics Write-Off and $65 Million Revenue Guidance Cut, Erasing Billions in Shareholder ValueNEW YORK, July 23, 2026 /PRNewswire/ -- SueWallSt notifies investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a class action lawsuit has been filed on behalf of shareholde...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       GeneDx
US81663L2007

NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are e...
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink
Do., 23.07.2026       GeneDx
US81663L2007

SAN FRANCISCO, July 22, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential....
Zur Nachricht
GeneDx
Charts & Research Termsheets Terminal
Permalink